Arrowstreet Capital, Limited Partnership Compugen LTD Transaction History

Arrowstreet Capital, Limited Partnership

  • $121 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$12.07 - $17.95 $168,980 - $251,300
-14,000 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$14.16 - $19.45 $198,240 - $272,300
14,000 New
14,000 $228,000
Q1 2020

May 15, 2020
SELL
$5.79 - $11.83 $81,639 - $166,803
-14,100 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$3.9 - $6.16 $54,990 - $86,856
14,100 New
14,100 $84,000

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.1M
Call Options Held
79.2K
Put Options Held
12.7K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $131M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email